to experience the full functionality of mail.com.
Enhanced by Google
October 18, 2016
Johnson & Johnson tops 3Q Street view but shares decline
Johnson & Johnson shares dropped Tuesday, despite the health care bellwether boosting its third-quarter profit 27 percent.
October 18, 2016
Pfizer to launch cheaper version of J&J immune drug Remicade
Drugmaker Pfizer said Monday that it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune ...
September 26, 2016
Drugmaker Pfizer decides not to break up business
Drug giant Pfizer says it won't split into two publicly traded companies, despite pressure from investors frustrated by its ...
August 22, 2016
Pfizer spends $14B on Medivation in cancer fight
Pfizer will pay about $14 billion to buy cancer drug developer Medivation in a cash deal aimed at fortifying its hold in one ...
August 17, 2016
Patent for J&J's Remicade invalidated, cheaper version looms
A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be ...
August 02, 2016
Pfizer beats Street 2Q forecasts despite big drop in profit
Rising sales of Pfizer Inc.'s key new medicines and prospects that more drugs will be approved soon have analysts speculating ...
August 01, 2016
Study points way to finding genes affecting depression risk
In a key advance for the study of depression, a comprehensive scan of human DNA has turned up the apparent hiding places of ...
July 26, 2016
Legislator: Pfizer can't complain about execution drug
The legislator who drafted a law that keeps most of Arkansas' lethal injection policy a secret said Tuesday that ...
July 25, 2016
APNewsBreak: Pfizer: Arkansas execution would 'misuse' drug
An execution drug obtained by the Arkansas prison system this month appears to have been made by a subsidiary of Pfizer, even ...
July 12, 2016
Lower-cost biotech drug gets thumbs up from FDA panel
The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed ...
July 06, 2016
Pfizer agrees to note addiction risks in opioid marketing
The city of Chicago and Pfizer announced an agreement Wednesday committing the drugmaker to disclosing the serious risks of ...
June 20, 2016
Rx pizza: 1 free meal can sway doctor prescribing
As little as one free meal from a drug company can influence which medicines doctors prescribe for Medicare patients, ...
May 24, 2016
Biden to host national cancer research summit in Washington
Vice President Joe Biden will bring together scientists, oncologists, donors and patients for a national conference on cancer ...
May 16, 2016
Pfizer buying skin drug maker Anacor for $5.2 billion
Pfizer is fortifying its key immunology and inflammation drug business, snapping up a small maker of skin disorder treatments ...
May 14, 2016
Correction: Execution Drugs-Pfizer story
In a story May 13 about a pharmaceutical company's refusal to sell states drugs used in lethal injections, The Associated ...
May 04, 2016
Panel: Painkiller training should be required for physicians
Doctors who prescribe painkillers should be required to undergo training aimed at reducing misuse and abuse of the ...
May 03, 2016
Corporate earnings keep falling, but there are signs of life
Are we there yet? It's another weak quarter on Wall Street, but there are some signs corporate America will come out of its ...
May 03, 2016
Pfizer tops Street 1Q forecasts on higher sales, lower taxes
Pfizer easily beat Wall Street expectations as the biggest U.S. drugmaker's first-quarter net income jumped 27 percent due ...
April 28, 2016
Shareholders criticize Pfizer after scrapped Allergan deal
Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to ...
April 27, 2016
Pfizer agrees to $785M settlement in drug discount case
Drugmaker Pfizer Inc. has agreed to pay nearly $785 million to resolve allegations that one of its companies failed to give ...